Status:

UNKNOWN

Combined Lactobacilli (Reuteri LMG P-27481 and GG ATCC 53103) to Prevent Antibiotic Associated Symptoms in Children

Lead Sponsor:

Università degli Studi dell'Insubria

Conditions:

Diarrhea Caused by Drug

Abdominal Pain

Eligibility:

All Genders

12-12 years

Phase:

NA

Brief Summary

This is a prospective multicenter pediatric double-blind, randomized placebo-controlled, parallel group clinical trial intended to evaluate the efficacy, safety and tolerability of a combined probioti...

Detailed Description

Eligible children will be randomly assigned to receive the combined probiotic study product (Noos, Roma, Italia)(BCCMTM Bacterial Collection of Ghent, Belgium, Italian Patent: 102016000011071, Interna...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (all of the following):
  • Children aged 12 months to 12 years
  • Proven or suspected bacterial infection
  • Inpatient children needed antibiotic treatment
  • Oral or intravenous or intramuscular antibiotic administration with at least 2 days of duration
  • Parental informed consent to the participation to the study
  • Exclusion Criteria:
  • Age below 12 months or above 12 years
  • Infections with no or only one day of antibiotic treatment
  • Sepsis or severe generalized infection
  • Pancreatitis
  • Known immunodeficiency or chronic gastrointestinal diseases or heart disease
  • Oncologic patients
  • Severe neurological impairment or lack of verbal expression
  • Enteral or parenteral nutrition
  • Gastrointestinal malformations or abdominal surgical interventions
  • Central line catheter
  • Acute or chronic diarrhea when starting antibiotics
  • Current or recent (in the last four weeks) use of any probiotic product
  • Antibiotic treatment started earlier than 24 hours before enrollment
  • Absence of parental consent

Exclusion

    Key Trial Info

    Start Date :

    May 13 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 13 2022

    Estimated Enrollment :

    216 Patients enrolled

    Trial Details

    Trial ID

    NCT04836013

    Start Date

    May 13 2021

    End Date

    April 13 2022

    Last Update

    May 4 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Silvia Salvatore

    Varese, Italy